EB research

We have a vision of a world where no one suffers from the painful skin condition Epidermolysis Bullosa (EB). Our research strategy focuses on what matters to people living with EB. Our ambition is to find treatments to lessen the day-to-day impact of EB, and cures to eradicate EB. We will fund science of the highest quality across the world that has the potential to deliver for EB patients.

DEBRA UK is the largest UK funder of EB research. We have invested over £20m and have been responsible, through funding pioneering research and working internationally, for establishing much of what is now known about EB.

Together we fight EB, together we will beat EB.

The devastating nature of EB drives our determination to do more than we have ever done to achieve our vision and end the suffering that EB brings. We are calling on the scientific community, funders and our industry partners to come and join us on this journey. We will drive a programme of world-class, innovative and collaborative research that will bring hope and improved outcomes for everyone living with EB.

Dr Sagair Hussain, DEBRA Director of Research